Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) EBT (2016 - 2025)

Jaguar Health (JAGX) has disclosed EBT for 11 consecutive years, with -$23.2 million as the latest value for Q4 2025.

  • Quarterly EBT fell 126.63% to -$23.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$54.0 million through Dec 2025, down 37.57% year-over-year, with the annual reading at -$54.0 million for FY2025, 37.57% down from the prior year.
  • EBT for Q4 2025 was -$23.2 million at Jaguar Health, down from -$9.6 million in the prior quarter.
  • The five-year high for EBT was -$7.9 million in Q3 2023, with the low at -$23.2 million in Q4 2025.
  • Average EBT over 5 years is -$11.8 million, with a median of -$10.6 million recorded in 2025.
  • The sharpest move saw EBT soared 42.51% in 2022, then plummeted 126.63% in 2025.
  • Over 5 years, EBT stood at -$14.3 million in 2021, then skyrocketed by 42.51% to -$8.2 million in 2022, then dropped by 13.08% to -$9.3 million in 2023, then dropped by 9.94% to -$10.2 million in 2024, then tumbled by 126.63% to -$23.2 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$23.2 million, -$9.6 million, and -$10.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.